AzTrials
AzTrials

TeenagerTreCogAMNCT01772394

Cognitive Remediation Therapy in Anorexia Nervosa

A study testing Cognitive Remediation Therapy in people with Teenager and Young Adult, run by Assistance Publique - Hôpitaux de Paris at 4 sites in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

"Clinicians from the Maudsley (IoP, London, UK) have specifically tailored a cognitive remediation therapy (CRT) for treating Anorexia Nervosa (AN). It is an intensive manualised training cognitive therapy which addresses the difficulties in flexibility and holistic processing that have been incriminated in AN. Read more about this study

Who is it for?
Ages 15 to 40 years, women only
Conditions the study is for
Teenager, Young Adult, Hospitalized
What is being tested?
Cognitive Remediation Therapy
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
120 participants
Where
4 sitesFrance
Study dates
Oct 2012to Jan 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 15 to 40 years
  • Women only
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • female;
  • 15-40 years old;
  • hospitalised for a diagnosis of Anorexia Nervosa (DSM-IV Revised criteria) in one of the three departments participating in this research ;
  • fluent in French;
  • who provide their informed consent (or as far as possible their parents for those under 18).

Who cannot join

  • previous history of neurological disorders;
  • actual substance use disorder;
  • schizophrenia;
  • presenting a related somatic illness (diabetes, Crohn's disease, metabolic illness) or a life-threatening condition.

Trial locations and contacts

4 sites in 1 country.

France4 sites
  • Clinique Villa Montsouris

    Paris, 75013

  • Institut Mutualiste Monsouris

    Paris, 75014

  • Maison de Solenn

    Paris, 75014

  • Assistance Publique - Hôpitaux de Paris, Hôpital Paul Brousse

    Villejuif, 94804

Other trials in France

About this study

Official title: Cognitive Remediation Therapy Effectiveness in Anorexia Nervosa: a Multicenter Randomized Clinical Study

"Clinicians from the Maudsley (IoP, London, UK) have specifically tailored a cognitive remediation therapy (CRT) for treating Anorexia Nervosa (AN). It is an intensive manualised training cognitive therapy which addresses the difficulties in flexibility and holistic processing that have been incriminated in AN. CRT has been found to improve AN's neuropsychological functioning and short term outcome. To our knowledge, no French speaking country has tested its effectiveness. Moreover, the question whether it is efficient for both anorexic restrictive and anorexic binge-purging patients remains unanswered.

The aim of the present study is to determine if CRT in AN adolescents and young adults has a favourable impact on cognitive functioning and clinical status. We will also explore whether the impact of CRT is similar in both anorexic restrictive and binge-purging subtypes. There will also be an Historical Control Group of patients, sixty, who received traditional medical interventions in a specialized inpatient unit for eating disorders (i.e., EVHAN study)."

Read the detailed description

"Several studies have documented that patients with Anorexia Nervosa (AN) display a trait of cognitive inflexibility (e;g., poor set-shifting performances on the Trail Making Task B), i.e. an inability to move flexibly back and forth between tasks, operations, or mental sets which allows for the adaptation of behaviour in response to changing demands within the environment. This cognitive inflexibility can be observed both during the acute phase of the illness and after weight restoration, and has been found to predict negative treatment outcomes. 'Weak central coherence' is another skill which is particularly problematic in AN. It refers to a cognitive style in which information remains fragmented as opposed to integrated, with processing occurring at the level of 'detail' as opposed to 'whole'. AN patients exhibit this detail focussed information-processing style (e.g., as measured by the Embedded Figures Test). To treat these difficulties, clinicians from the Institute of Psychiatry (London, UK) have specifically tailored a treatment for AN. Cognitive remediation therapy (CRT) is an intensive training cognitive therapy that encourages people to reflect on and try to modify the way they think, with a particular focus on improving cognitive flexibility. It is a manualised therapist-led intervention consisting of multiple versions of a variety of tasks and mental exercises that address the difficulties in flexibility and holistic processing. CRT is a 10-sessions long program that has been found to improve AN's neuropsychological functioning and short term outcome. To our knowledge, no French speaking country has tested its effectiveness. Moreover, the question whether it is efficient for both anorexic restrictive and anorexic binge-purging patients remains unanswered.

To address these issues, we designed a multicenter randomized clinical trial on the effectiveness of CRT in AN adolescents and young adults.

Main hypothesis: AN patients treated with CRT present a better clinical status than those treated by a control therapy.

Recruitment and Procedure: 120 female adolescents or young adults [15-40 years old] AN (60 Anorexic Restrictive; 60 Anorexic Binge-Purging) will be recruited among the patients of specialized ED care units of three hospitals: PAUL BROUSSE, INSTITUT MUTUALISTE MONTSOURIS, COCHIN-MAISON DE SOLENN. In each group of AN subtype, the patients will be randomly allocated to one of the two treatment arms: CRT or Sham Therapy (ST). Each therapy is manualised and includes 10 sessions over a period of 5 weeks (2 sessions/week). All the patients will be assessed just prior the beginning and after the end of the CRT/ST, at 6 months and 1 year of follow-up."

Being tested
Cognitive Remediation Therapy, Sham Therapy
Keywords
Anorexia Nervosa, Cognitive remediation therapy, Randomized clinical trial
Medical subject headings
Anorexia Nervosa

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Cognitive Remediation TherapyBehavioural

    Also called CRT

    Cognitive remediation therapy (CRT) is an intensive training cognitive therapy that encourages people to reflect on and try to modify the way they think, with a particular focus on improving cognitive flexibility. It is a manualised therapist-led intervention consisting of multiple versions of a variety of tasks and mental exercises that address the difficulties in flexibility and holistic processing. CRT is an individual 10-sessions long program (2 sessions per week).

  • Sham TherapyBehavioural

    Also called ST

    The Sham therapy (ST) has been designed to match the CRT format: an individual manualised therapist-led 10-sessions long program (2 sessions per week). ST sessions have been designed so as to avoid set-shifting and central coherence training. Rather, ST is a manualised sham intervention consisting of multiple exercises on 3 domains: soft physical activity, emotional expression recognition and interpersonal functioning.

Study groups in NCT01772394
Study groupRoleWhat they receive
Cognitive Remediation Therapy (CRT)Active comparatorActive : CRT
Receives: Behavioral: Cognitive Remediation Therapy
Sham Therapy (ST)Sham comparatorSham : ST
Receives: Behavioral: Sham Therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Neuropsychological functioning:Wisconsin Sorting Card Test (WSCT)

    The WSCT are two neuropsychological tests that have been consistently used to highlight poor set-shifting skills in Anorexia nervosa.

    Measured: 1 week post-therapy

  2. Clinical status Evaluation:Morgan and Russell Global Outcome Assessment Scale (GOAS);

    The Global Outcome Assessment Schedule (GOAS; Morgan \& Hayward, 1998) is a standard measure of outcome in eating disorders; it includes 14 subscales evaluating five dimensions: (A) Food Intake and body weight ; (B) Menstrual status; (C) Mental state ; (D) Psychosexual state ; (E) Socioeconomic status and social functioning.

    Measured: up to 1 year of follow-up

Secondary outcomes (15)
  1. Central coherence

    Central coherence: Rey figure;

    Measured: 1 week post-therapy

  2. Nutritional status

    body mass index

    Measured: 1 week post-therapy

  3. Nutritional status

    body mass index

    Measured: 6 months of follow-up

  4. Nutritional status

    body mass index

    Measured: 1 year of follow-up

  5. Self-reported eating disorders symptoms

    Eating Disorder Examination Questionnaire and Body Shape Questionnaire

    Measured: 1 week post-therapy

  6. Self-reported eating disorders symptoms

    Eating Disorder Examination Questionnaire and Body Shape Questionnaire

    Measured: 1 year of follow-up

  7. Self-reported Cognitive style;

    Detail and Flexibility Questionnaire

    Measured: 1 week post-therapy

  8. Self-reported Cognitive style;

    Detail and Flexibility Questionnaire

    Measured: 1 year of follow-up

  9. Self-reported treatment satisfaction

    Helping Alliance Questionnaire and Patient Satisfaction Questionnaire

    Measured: 1 week post-therapy

  10. Self-reported motivation to change

    the Maudsley motivation to change questionnaire

    Measured: 1 week post-therapy

  11. Self-reported motivation to change

    the Maudsley motivation to change questionnaire

    Measured: 6 months of follow-up

  12. Self-reported motivation to change

    the Maudsley motivation to change questionnaire

    Measured: 1 year of follow-up

  13. Self-reported self-esteem

    Rosenberg self-esteem Questionnaire

    Measured: 1 week post-therapy

  14. Self-reported self-esteem

    Rosenberg self-esteem Questionnaire

    Measured: 1 year of follow-up

  15. Flexibility evolution : Trail Making Test (TMT)

    Neuropsychological functioning

    Measured: 1 week post-therapy

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Jan 2013 (estimated)
  2. Study startOct 2012
  3. Primary completionJun 2016
  4. Study completionJan 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
120 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01772394
Sponsor's protocol ID
RCB-2011-A01280-41
Other IDs
P091123
Acronym
TreCogAM
Status last verified
Jan 2017
First submitted
17 Jan 2013
Last updated
16 Jan 2017
Results posted
No
Data monitoring committee
Yes

Publications

  • Maria AS, Barry C, Ringuenet D, Falissard B, Group T, Berthoz S. Subjective cognitive rigidity and attention to detail: A cross-cultural validation of the Detail and Flexibility Questionnaire (DFlex) in a French clinical sample. J Clin Exp Neuropsychol. 2020 Dec;42(10):1059-1071. doi: 10.1080/13803395.2020.1842333. Epub 2020 Dec 4.

    PubMed 33274668
  • Maria AS, Bourdier L, Duclos J, Ringuenet D, Berthoz S. Psychometric properties of the French version of a scale measuring perceived emotional intelligence : the Trait Meta-Mood Scale (TMMS). Can J Psychiatry. 2016 Oct;61(10):652-62. doi: 10.1177/0706743716639936. Epub 2016 Mar 28.

    PubMed 27310229

Questions about this trial

What is this clinical trial studying?

A study testing Cognitive Remediation Therapy in people with Teenager and Young Adult, run by Assistance Publique - Hôpitaux de Paris at 4 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Jan 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 4 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Neuropsychological functioning:Wisconsin Sorting Card Test (WSCT) (time frame: 1 week post-therapy). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01772394, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Jan 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in